Evotec starts Phase 1 trial for Jst-018 orthopoxvirus antibodies
Evotec initiated a Phase 1 trial for Jst-018 antibodies targeting orthopoxviruses.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.